Glaucoma is a very serious eye disorder that affects millions of people throughout the world. Approximately 120,000 people in the United States have lost their eyesight after developing it. There is currently no cure for glaucoma, but there are a lot of treatments that can delay or stop the problems from developing. There are a number of new developments that may make it easier to fight the disease in the future.
New Advances in Glaucoma Treatments
Several organizations throughout the world have recently announced some steps that they are taking to fight glaucoma. Here are some breakthroughs that doctors may take advantage of in the near future.
Electronic Eye Sensors
A team of researchers from Washington have recently announced that they have developed a new sensor that can identify symptoms of glaucoma. The new device will provide real-time information so affected patients can see their doctor for treatment before the disease progresses.
Novartis Eyecare Unit
Novartis, a Swiss medical technology company, has recently announced that it has created a new eyecare unit that can help treat glaucoma. The new device will moderate intraocular pressure to help patients suffering from glaucoma, ocular hypertension and other related eye diseases.
Dealing with glaucoma becomes more difficult in the later stages. This device may be one of the best treatments for people that are trying to save their eyesight. The European Commission has approved the new treatment, so doctors throughout Europe may start using it in the near future.
Aerie Starts New Glaucoma Trial
Aerie Pharmaceuticals is a company that was started by two Duke University professors. The company has recently announced that it has developed a new treatment for glaucoma. Canadian regulators have given Aerie permission to conduct a trial. If the treatment is ultimately approved, then it may be made available throughout Canada and the United States. The treatment could be rolled out in other countries in the future shortly after.
Treating Glaucoma Will Become Priority in the Years to Come
Glaucoma is the second biggest cause of blindness in people of European descent. Medical experts have been pursuing new treatments to deal with it over the past few years. They hope to implement their new treatments in the next few years to reduce the number of people that lose eyesight from it.
Many doctors are expected to recommend these treatments after they are approved. They will be most likely to propose them to people over 35, because that is the typical age of onset of the disease.